Skip to main content
Caplight Logo









Voinosis

Voinosis

Private
SeoulHealthcare & Life Scienceshttps://voinosis.com/

Last Round

Strategic

Jul 7, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Voinosis is a healthcare technology company that develops AI-powered voice analysis solutions for the early detection and management of cognitive impairment, dementia, and hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

voice biomarkerdigital healthcognitive impairment detectiondementia screeningai diagnosticsdigital therapeuticsvoice analysisDTxmedical aispeech biomarkerclinical decision supportremote patient monitoringRPMvocal biomarkerhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Voinosis Comparables

Compare Voinosis with similar companies based on industry and business-model similarity.

Voinosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AIBLE Therapeutics
89%
HAII
81%
Accexible
81%

Voinosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 7, 2026
Early FundingJun 4, 2026
GrantMar 1, 2026

Key People

Founding team and executive leadership

Grace Jung Eun Shin

Chief Executive Officer Voinosis.inc

Executive Team

Voinosis Investors

Notable investors and investment history

Voinosis investors
InvestorRounds
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2026

    Daewoong Pharmaceutical participated in the round.

  • Jun 4, 2026

    Raised $4M in early funding.

Voinosis Filings

Explore SEC and related filing metadata, where available.

Voinosis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Voinosis's valuation, stock price, and market status.

Is Voinosis a public or private company?

Voinosis is a private company.

What is the current stock price of Voinosis?

Voinosis is a private company with no public stock price. Caplight tracks Voinosis's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Voinosis worth (valuation)?

Valuation information for Voinosis is not publicly available.

Can I buy Voinosis stock?

Voinosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Voinosis's last funding round?

Voinosis's most recent funding round was Strategic on July 7, 2026.

Who are the main investors in Voinosis?

Key investors in Voinosis include Government of South Korea.

Will Voinosis IPO soon?

No public IPO plans have been announced for Voinosis.

How can I track Voinosis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Voinosis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range5
Year Founded2019
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?